Alliance Boots Pays $91 Million for Stake in Nanjing Pharma

Alliance Boots has received China regulatory permission to acquire a 12% stake in Nanjing Pharmaceutical, paying $91 million for newly issued shares of Nanjing Pharma. The company does not, however, intend to stop here: Boots has announced it will use M&A to attain its goal of becoming the largest pharmaceutical distributor in China. Boots describes itself as a pharmacy-led retail health and beauty company that is also involved in drug wholesaling and distribution. More details.... Stock Symbol: (SHA: 600713) Share this with colleagues: // //